Article Details

Antisense Therapeutics (ASX:ANP) dosing of muscular dystrophy drug on hold

Retrieved on: 2021-08-12 01:41:15

Tags for this article:

Click the tags to see associated articles and topics

Antisense Therapeutics (ASX:ANP) dosing of muscular dystrophy drug on hold. View article details on hiswai:

Excerpt

Antisense Therapeutics (ANP) applies for the lifting of a partial clinical hold that limits dosing of its muscular dystrophy drug; After positive feedback ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up